Price Movement and Market Context
The stock closed at ₹1,647.40 on 6 Feb 2026, marking a 2.14% increase from the previous close of ₹1,612.90. Intraday, the share price fluctuated between ₹1,596.75 and ₹1,652.85, remaining well below its 52-week high of ₹1,964.80 but comfortably above the 52-week low of ₹1,057.65. This price action suggests a moderate recovery phase, yet the broader technical signals indicate caution.
Comparatively, CARE Ratings has outperformed the Sensex over multiple time horizons. The stock delivered a 4.81% return over the past week against the Sensex’s 0.91%, and a robust 36.37% gain over the last year compared to the Sensex’s 6.44%. Over five years, the stock’s return of 207.38% dwarfs the Sensex’s 64.22%, underscoring its long-term growth credentials despite recent volatility.
Technical Indicator Analysis
The technical landscape for CARE Ratings is mixed, with weekly and monthly indicators sending somewhat divergent signals. The weekly Moving Average Convergence Divergence (MACD) remains bullish, suggesting positive momentum in the short term. However, the monthly MACD has turned mildly bearish, indicating potential weakening momentum over a longer horizon.
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no definitive signal, hovering in neutral territory. This lack of directional RSI momentum implies that the stock is neither overbought nor oversold, leaving room for either a continuation or reversal of the current trend.
Bollinger Bands provide a more optimistic view, with both weekly and monthly readings bullish. This suggests that price volatility is contained within an upward channel, supporting the recent price gains. However, daily moving averages have shifted to mildly bearish, signalling that short-term price action may face resistance or consolidation.
The Know Sure Thing (KST) indicator aligns with this mixed picture: bullish on the weekly timeframe but mildly bearish monthly. This divergence highlights the importance of monitoring both short- and long-term trends before making investment decisions.
Additional technical frameworks such as Dow Theory and On-Balance Volume (OBV) further complicate the outlook. Dow Theory classifies the weekly trend as mildly bearish, while the monthly trend shows no clear direction. Similarly, OBV is mildly bearish weekly but neutral monthly, indicating that volume trends do not strongly support a sustained rally at present.
Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.
- - Consistent quarterly delivery
- - Proven staying power
- - Stability with growth
Mojo Score and Rating Update
MarketsMOJO has recently downgraded CARE Ratings Ltd from a Hold to a Sell rating, reflecting a Mojo Score of 48.0 as of 5 Feb 2026. This downgrade is indicative of the deteriorating technical and fundamental outlook, with the company’s Market Cap Grade standing at a modest 3. The rating change underscores the cautious stance investors should adopt given the current technical signals and sector dynamics.
Sector and Industry Positioning
Operating within the capital markets sector, CARE Ratings faces headwinds from broader market volatility and sector-specific challenges. While the company’s long-term returns have been impressive, recent technical shifts suggest that momentum is waning. Investors should weigh these factors carefully against the backdrop of the sector’s cyclical nature and regulatory environment.
Investment Implications
The mildly bearish technical trend, combined with mixed indicator signals, suggests that CARE Ratings Ltd may be entering a phase of consolidation or moderate correction. The bullish weekly MACD and Bollinger Bands offer some support for short-term gains, but the monthly bearish signals and daily moving averages counsel prudence.
Investors with a medium- to long-term horizon might consider monitoring the stock for confirmation of trend reversal or further deterioration before committing additional capital. The absence of strong RSI signals indicates that the stock is not yet oversold, so a deeper correction cannot be ruled out.
Why settle for CARE Ratings Ltd? SwitchER evaluates this Capital Markets small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Comparative Performance and Outlook
CARE Ratings’ outperformance relative to the Sensex over one week (4.81% vs 0.91%) and one year (36.37% vs 6.44%) highlights its resilience amid market fluctuations. However, the stock’s 1-month return of -4.98% versus the Sensex’s -2.49% signals recent short-term weakness. This volatility is consistent with the technical indicators’ mixed signals and the shift to a mildly bearish trend.
Longer-term returns remain impressive, with a 3-year gain of 172.19% compared to the Sensex’s 36.94%, and a 5-year return of 207.38% versus 64.22%. These figures demonstrate the company’s strong growth trajectory over time, though recent technical changes suggest investors should remain vigilant.
Conclusion
CARE Ratings Ltd is currently navigating a complex technical environment characterised by a shift from sideways to mildly bearish momentum. While short-term indicators such as weekly MACD and Bollinger Bands remain bullish, monthly and daily signals point to caution. The recent downgrade to a Sell rating by MarketsMOJO further emphasises the need for careful analysis before investment decisions.
Investors should closely monitor the stock’s price action and technical indicators in the coming weeks to identify whether the bearish signals consolidate or if a renewed bullish trend emerges. Given the company’s strong historical returns and sector positioning, a balanced approach combining technical analysis with fundamental insights is advisable.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
